Stocklytics Platform
Asset logo for symbol PACB
Pacific Biosciences of California
PACB63
$1.98arrow_drop_down10.20%-$0.22
Penny Stock
Asset logo for symbol PACB
PACB63

$1.98

arrow_drop_down10.20%

Performance History

Chart placeholder
Key Stats
Open$2.25
Prev. Close$2.20
EPS-1.46
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$596.86M
PE Ratio-
LOWHIGH
Day Range2.15
2.30
52 Week Range1.16
10.65
Ratios
EPS-1.46

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Pacific Biosciences of California (PACB)

Pacific Biosciences of California Inc (PACB) is a biotechnology company that specializes in genomic sequencing. The company develops and manufactures DNA sequencing systems, including the PacBio RS II Sequencer and the Sequel System. These systems enable scientists to study complex biological systems, such as human genetics and microbial genomics. With its advanced technology and scientific expertise, PACB has become a leader in the field of long-read sequencing.
PACB's stock price history reflects the growth and potential of the company. Over the years, the stock has experienced fluctuations, but it has shown an overall upward trajectory. Investors have recognized the value of PACB's technology and its potential to revolutionize biomedical research. As a result, the stock has attracted attention and gained popularity among both institutional and individual investors.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Christian O. Henry M.B.A.
Headquarters
Menlo Park
Employees
769
Exchange
NASDAQ
add Pacific Biosciences of California  to watchlist

Keep an eye on Pacific Biosciences of California

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Pacific Biosciences of California 's (PACB) price per share?

The current price per share for Pacific Biosciences of California (PACB) is $1.98. The stock has seen a price change of -$0.23 recently, indicating a -10.2% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Pacific Biosciences of California (PACB)?

For Pacific Biosciences of California (PACB), the 52-week high is $10.65, which is 437.88% from the current price. The 52-week low is $1.16, the current price is 70.69% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Pacific Biosciences of California (PACB) a growth stock?

Pacific Biosciences of California (PACB) has shown an average price growth of -3.13% over the past three years. It has received a score of 2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pacific Biosciences of California as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Pacific Biosciences of California (PACB) stock price performance year to date (YTD)?

As of the latest data, Pacific Biosciences of California (PACB) has a year-to-date price change of -79.35%. Over the past month, the stock has experienced a price change of -3.41%. Over the last three months, the change has been 32.89%. Over the past six months, the figure is 2.59%. Looking at a longer horizon, the five-year price change stands at -58.92%.
help

Is Pacific Biosciences of California (PACB) a profitable company?

Pacific Biosciences of California (PACB) has a net income of -$306.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 20.12% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -157.92% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $200.52M, with a revenue growth rate of 56.29%, providing insight into the company's sales performance and growth. The gross profit is $40.34M. Operating income is noted at -$310.36M. Furthermore, the EBITDA is -$263.61M.
help

What is the market capitalization of Pacific Biosciences of California (PACB)?

Pacific Biosciences of California (PACB) has a market capitalization of $588.66M. The average daily trading volume is 2.11, indicating the stock's liquidity and investor engagement.

News

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level